Free Trial

This company has been marked as potentially delisted and may not be actively trading.

ETAO International (ETAO) Competitors

ETAO International logo

ETAO vs. SHLT, CMRA, GNCA, GNCAQ, NVOS, ARDS, BTTX, STAB, NMRD, and UPHL

Should you be buying ETAO International stock or one of its competitors? The main competitors of ETAO International include SHL Telemedicine (SHLT), Comera Life Sciences (CMRA), Genocea Biosciences (GNCA), Genocea Biosciences (GNCAQ), Novo Integrated Sciences (NVOS), Aridis Pharmaceuticals (ARDS), Better Therapeutics (BTTX), Statera Biopharma (STAB), Nemaura Medical (NMRD), and UpHealth (UPHL). These companies are all part of the "medical" sector.

ETAO International vs. Its Competitors

ETAO International (NASDAQ:ETAO) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, dividends, media sentiment, valuation, institutional ownership, profitability and analyst recommendations.

ETAO International has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500.

In the previous week, ETAO International had 1 more articles in the media than SHL Telemedicine. MarketBeat recorded 1 mentions for ETAO International and 0 mentions for SHL Telemedicine. ETAO International's average media sentiment score of 0.00 equaled SHL Telemedicine'saverage media sentiment score.

Company Overall Sentiment
ETAO International Neutral
SHL Telemedicine Neutral

0.2% of ETAO International shares are held by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are held by institutional investors. 20.8% of ETAO International shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
ETAO InternationalN/A N/A N/A
SHL Telemedicine N/A N/A N/A

SHL Telemedicine has lower revenue, but higher earnings than ETAO International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ETAO International$58.89M0.00-$896.68MN/AN/A
SHL Telemedicine$55.94M0.60-$7.06MN/AN/A

Summary

ETAO International beats SHL Telemedicine on 4 of the 6 factors compared between the two stocks.

Get ETAO International News Delivered to You Automatically

Sign up to receive the latest news and ratings for ETAO and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ETAO vs. The Competition

MetricETAO InternationalOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$2K$33.61M$5.50B$9.02B
Dividend YieldN/AN/A5.38%4.10%
P/E RatioN/AN/A27.6020.30
Price / SalesN/A0.60369.54104.24
Price / CashN/A54.0336.6357.47
Price / BookN/A0.398.055.68
Net Income-$896.68M-$7.06M$3.18B$249.13M

ETAO International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ETAO
ETAO International
N/AN/AN/AN/A$2K$58.89M0.003,600
SHLT
SHL Telemedicine
N/A$2.05
flat
N/AN/A$33.61M$55.94M0.00583
CMRA
Comera Life Sciences
N/A$0.00
flat
N/A-99.2%$6K$1.00M0.002
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6K$1.91M0.0070
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6KN/A0.0070
NVOS
Novo Integrated Sciences
N/A$0.00
-92.5%
N/A-100.0%$6K$13.52M0.00170Gap Down
ARDS
Aridis Pharmaceuticals
N/AN/AN/A-99.8%$5K$3.09M0.0030
BTTX
Better Therapeutics
N/AN/AN/A-99.0%$5KN/A0.0040
STAB
Statera Biopharma
N/A$0.00
flat
N/A-83.3%$5KN/A0.0020
NMRD
Nemaura Medical
1.0513 of 5 stars
N/AN/A-99.8%$4K$3.02K0.0040
UPHL
UpHealth
N/A$0.00
flat
N/A-100.0%$4K$130M0.001,750

Related Companies and Tools


This page (NASDAQ:ETAO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners